Transgelin is upregulated in stromal cells of lymph node
positive breast cancer

J 2016

Transgelin is upregulated in stromal cells of lymph node positive breast cancer

DVOŘÁKOVÁ, Monika; Jarmila SOBOTKOVÁ; Iva PROCHÁZKOVÁ; Juraj LENČO; Rudolf NENUTIL et al.

Základní údaje

Originální název

Transgelin is upregulated in stromal cells of lymph node positive breast cancer

Autoři

DVOŘÁKOVÁ, Monika; Jarmila SOBOTKOVÁ; Iva PROCHÁZKOVÁ; Juraj LENČO; Rudolf NENUTIL a Pavel BOUCHAL

Vydání

Journal of Proteomics, Amsterdam, ELSEVIER SCIENCE BV, 2016, 1874-3919

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10600 1.6 Biological sciences

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.914

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14310/16:00088069

Organizační jednotka

Přírodovědecká fakulta

Klíčová slova anglicky

Breast cancer; Lymph node metastasis; Transgelin; Transgelin-2; Proteomics

Štítky

AKR, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 26. 4. 2021 12:57, Mgr. Tereza Miškechová

Anotace

V originále

Transgelin and transgelin-2 have been discussed as potential markers of various cancers. Here we identified increased transgelin level in lymph node positive vs. negative, low grade primary breast cancer tissues using 2-DE in the cohort of 12 patients.Wefurther clinically validated 2-DE results in an independent cohort of 48 lowgrade breast cancer patients through untargeted and targeted proteomics analysis (iTRAQ-2D-LC–MS/MS, mTRAQSRM), at transcript level and using immunohistochemistry. Another group of 48 high grade tumors of different breast cancer subtypes was analyzed together with the low grade samples to test transgelin specificity for low grade tumors and to study transgelin relation to known molecular markers and histological features. The results confirmed transgelin connection with the lymph node metastasis. As a marker of a reactive tumor stroma, transgelin can be connected with the higher risk of metastasis development. Moreover, we observed significant down-regulation of transgelin in high vs. low grade tumors caused by decreased content of stromal cells (mainly expressing transgelin) in high grade tumor tissue. We also analyzed expression of transgelin-2 in the second cohort using proteomics and immunohistochemistry. Transgelin-2 was mainly expressed by epithelial cancer cells and its levels were increased in metastatic and poorly differentiated tumors.

Návaznosti

GA14-19250S, projekt VaV

Název: Nový panel proteinů korelujících se stavem lymfatických uzlin u low-grade nádorů prsu: Klinická verifikace a úloha v invazivitě nádorových buněk

Investor: Grantová agentura ČR, Nový panel proteinů korelujících se stavem lymfatických uzlin u low-grade nádorů prsu: Klinická verifikace a úloha v invazivitě nádorových buněk

90004, velká výzkumná infrastruktura

Název: BBMRI-CZ

Citovat

DVOŘÁKOVÁ, Monika; Jarmila SOBOTKOVÁ; Iva PROCHÁZKOVÁ; Juraj LENČO; Rudolf NENUTIL a Pavel BOUCHAL. Transgelin is upregulated in stromal cells of lymph node positive breast cancer. Journal of Proteomics. Amsterdam: ELSEVIER SCIENCE BV, 2016, roč. 132, January, s. 103-111. ISSN 1874-3919. Dostupné z: https://doi.org/10.1016/j.jprot.2015.11.025.

@article{1350932,
   author = {Dvořáková, Monika and Sobotková, Jarmila and Procházková, Iva and Lenčo, Juraj and Nenutil, Rudolf and Bouchal, Pavel},
   article_location = {Amsterdam},
   article_number = {January},
   doi = {https://doi.org/10.1016/j.jprot.2015.11.025},
   keywords = {Breast cancer; Lymph node metastasis; Transgelin; Transgelin-2; Proteomics},
   language = {eng},
   issn = {1874-3919},
   journal = {Journal of Proteomics},
   title = {Transgelin is upregulated in stromal cells of lymph node positive breast cancer},
   url = {https://www.sciencedirect.com/science/article/pii/S1874391915301986?via%3Dihub},
   volume = {132},
   year = {2016}
}

TY  - JOUR
ID  - 1350932
AU  - Dvořáková, Monika - Sobotková, Jarmila - Procházková, Iva - Lenčo, Juraj - Nenutil, Rudolf - Bouchal, Pavel
PY  - 2016
TI  - Transgelin is upregulated in stromal cells of lymph node positive breast cancer
JF  - Journal of Proteomics
VL  - 132
IS  - January
SP  - 103-111
EP  - 103-111
PB  - ELSEVIER SCIENCE BV
SN  - 18743919
KW  - Breast cancer
KW  - Lymph node metastasis
KW  - Transgelin
KW  - Transgelin-2
KW  - Proteomics
UR  - https://www.sciencedirect.com/science/article/pii/S1874391915301986?via%3Dihub
N2  - Transgelin and transgelin-2 have been discussed as potential markers of various cancers. Here we identified increased transgelin level in lymph node positive vs. negative, low grade primary breast cancer tissues using 2-DE in the cohort of 12 patients.Wefurther clinically validated 2-DE results in an independent cohort of 48 lowgrade breast cancer patients through untargeted and targeted proteomics analysis (iTRAQ-2D-LC–MS/MS, mTRAQSRM), at transcript level and using immunohistochemistry. Another group of 48 high grade tumors of different breast cancer subtypes was analyzed together with the low grade samples to test transgelin specificity for low grade tumors and to study transgelin relation to known molecular markers and histological features. The results confirmed transgelin connection with the lymph node metastasis. As a marker of a reactive tumor stroma, transgelin can be connected with the higher risk of metastasis development. Moreover, we observed significant down-regulation of transgelin in high vs. low grade tumors caused by decreased content of stromal cells (mainly expressing transgelin) in high grade tumor tissue. We also analyzed expression of transgelin-2 in the second cohort using proteomics and immunohistochemistry. Transgelin-2 was mainly expressed by epithelial cancer cells and its levels were increased in metastatic and poorly differentiated tumors.
ER  -

DVOŘÁKOVÁ, Monika; Jarmila SOBOTKOVÁ; Iva PROCHÁZKOVÁ; Juraj LENČO; Rudolf NENUTIL a Pavel BOUCHAL. Transgelin is upregulated in stromal cells of lymph node positive breast cancer. \textit{Journal of Proteomics}. Amsterdam: ELSEVIER SCIENCE BV, 2016, roč.~132, January, s.~103-111. ISSN~1874-3919. Dostupné z: https://doi.org/10.1016/j.jprot.2015.11.025.

Přehled o publikaci